摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,4R,6R)-6-[(2S,3R)-3-[(3R)-6,8-bis[(4-methoxyphenyl)methoxy]-5-methyl-1-oxo-3,4-dihydroisochromen-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxane-2-carbonitrile | 864514-29-4

中文名称
——
中文别名
——
英文名称
(2S,4R,6R)-6-[(2S,3R)-3-[(3R)-6,8-bis[(4-methoxyphenyl)methoxy]-5-methyl-1-oxo-3,4-dihydroisochromen-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxane-2-carbonitrile
英文别名
——
(2S,4R,6R)-6-[(2S,3R)-3-[(3R)-6,8-bis[(4-methoxyphenyl)methoxy]-5-methyl-1-oxo-3,4-dihydroisochromen-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxane-2-carbonitrile化学式
CAS
864514-29-4
化学式
C38H45NO9
mdl
——
分子量
659.777
InChiKey
NKKAZJVVXNDYRG-WITSCBGESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    48
  • 可旋转键数:
    12
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    137
  • 氢给体数:
    2
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and Complete Stereochemical Assignment of Psymberin/Irciniastatin A
    作者:Xin Jiang、Jorge García-Fortanet、Jef K. De Brabander
    DOI:10.1021/ja0537068
    日期:2005.8.1
    We describe a concise and flexible synthetic avenue for the preparation of compounds with structures relevant to those proposed for the novel marine-derived differential cytotoxins psymberin and irciniastatin A. Our efforts led to their complete stereochemical assignment and the notion that psymberin and irciniastatin A are identical compounds. Our total synthesis features an interesting termini-differentiating
    我们描述了一种简洁灵活的合成途径,用于制备结构与新型海洋衍生差异细胞毒素 psymberin 和 irciniastatin A 相关的化合物。我们的努力导致了它们的完整立体化学分配以及 psymberin 和 irciniastatin A 相同的概念化合物。我们的全合成具有从 C2 对称双烯烃前体获得的二醛的有趣的末端差异化乳醇化、差向异构腈的温和铂催化水解、制备灵敏的亚胺酸甲酯的新方案和一锅法转化这些亚胺酯转化为 N-酰基胺。从片段 5-7 开始(每个片段准备 7-8 个步骤,
  • Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds
    申请人:Brabander De Jef
    公开号:US20070015821A1
    公开(公告)日:2007-01-18
    The invention relates to the synthesis and complete stereochemical assignments of cytotoxic compounds such as compound 28-a and its stereoisomers: The invention further provides processes for making the compounds, their synthetic intermediates, and for methods of using the compounds and their pharmaceutical compositions for the treatment of neoplastic diseases.
    该发明涉及合成和对细胞毒性化合物的完全立体化学赋值,如化合物28-a及其立体异构体。该发明还提供了制备这些化合物、它们的合成中间体的方法,以及使用这些化合物及其药物组合物治疗肿瘤性疾病的方法。
  • [EN] SYNTHESIS AND COMPLETE STEREOCHEMICAL ASSIGNMENT OF PSYMBERIN/IRCINIASTATIN FOR ANTI-TUMOR USE<br/>[FR] SYNTHESE ET ATTRIBUTION STEREOCHIMIQUE COMPLETE DE PSYMBERINE/IRCINIASTATINE POUR UNE APPLICATION ANTI-TUMORALE
    申请人:UNIV TEXAS
    公开号:WO2007011629A2
    公开(公告)日:2007-01-25
    [EN] The invention relates to the synthesis and complete stereochemical assignments of cytotoxic compounds such as compound 28-a and its stereoisomers. The invention further provides processes for making the compounds, their synthetic intermediates, and for methods of using the compounds and their pharmaceutical compositions for the treatment of neoplastic diseases.
    [FR] La présente invention concerne la synthèse et les attributions stéréochimiques complètes de composés cytotoxiques, tels que le composé 28-a et ses stéréoisomères. La présente invention concerne également des procédés permettant de fabriquer ces composés; leurs produits intermédiaires de synthèse ainsi que des méthodes permettant d'utiliser ces composés et les compositions pharmaceutiques destinées au traitement de maladies néoplasiques.
  • Studies toward the Unique Pederin Family Member Psymberin: Full Structure Elucidation, Two Alternative Total Syntheses, and Analogs
    作者:Yu Feng、Xin Jiang、Jef K. De Brabander
    DOI:10.1021/ja3057612
    日期:2012.10.17
    Two synthetic approaches to psymberin have been accomplished. A highly convergent first generation synthesis led to the complete stereochemical assignment and demonstrated that psymberin and irciniastatin A are identical compounds. This synthesis featured a diastereoselective aldol coupling between the aryl fragment and a central tetrahydropyran core and a novel one-pot procedure to convert an amide, via intermediacy of a sensitive methyl imidate, to the N-acyl aminal reminiscent of psymberin. The highlights of the second generation synthesis include an efficient iridium-catalyzed enantioselective bisallylation of neopentyl glycol and a stepwise Sonogashira coupling/cycloisomerization/reduction sequence to construct the dihydroisocoumarin unit. The two synthetic avenues were achieved in 17-18 steps (longest linear sequence, similar to 14-15 isolations) from 3 fragments prepared in 7-8 (first generation) and 3-8 (second generation) steps each. This convergent approach allowed for the preparation of sufficient amounts of psymberin (similar to 0.5 g) for follow-up biological studies. Meanwhile, our highly flexible strategy enabled the design and synthesis of multiple analogs, including a psymberin pederin hybrid, termed psympederin, that proved crucial to a comprehensive understanding of the chemical biology of psymberin and related compounds that will be described in a subsequent manuscript.
查看更多